Some functional aspects of apolipoproteins: apoLp-Ala inhibition of lipoprotein lipase and deinhibition by monoolein.
D000409:Alanine / Q000494:pharmacology; D000818:Animals; D001059:Apoproteins / Q000097:blood / Q000302:isolation & purification / Q000494:pharmacology* / Q000502:physiology; D001796:Blood Protein Disorders / Q000097:blood; D002250:Carbon Radioisotopes; D002417:Cattle; D004075:Diglycerides / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005971:Glutamates / Q000494:pharmacology; D005989:Glycerides / Q000494:pharmacology*; D006801:Humans; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors*; D008074:Lipoproteins / Q000097:blood / Q000302:isolation & purification / Q000494:pharmacology* / Q000502:physiology; D008892:Milk / Q000201:enzymology; D009829:Oleic Acids / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013997:Time Factors; D014304:Triolein / Q000494:pharmacology
D001059:Apoproteins; D002250:Carbon Radioisotopes; D004075:Diglycerides; D005971:Glutamates; D005989:Glycerides; D008074:Lipoproteins; D009829:Oleic Acids; D014304:Triolein; D008071:Lipoprotein Lipase; D000409:Alanine